×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [10]
内容类型
期刊论文 [8]
会议论文 [2]
发表日期
2019 [2]
2018 [4]
2016 [1]
2015 [3]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共10条,第1-10条
帮助
限定条件
专题:复旦大学上海医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
期刊论文
ONCOLOGIST, 2019, 卷号: 24, 期号: 8
作者:
Zhou, Ai-Ping
;
Bai, Yuxian
;
Song, Yan
;
Luo, Hong
;
Ren, Xiu-Bao
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2019/12/05
Anlotinib
Metastatic renal cell cancer
Phase II clinical trial
Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection
期刊论文
PLOS PATHOGENS, 2019, 卷号: 15, 期号: 4
作者:
Yang, Feifei
;
Yu, Xueping
;
Zhou, Chenliang
;
Mao, Richeng
;
Zhu, Mengqi
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2019/12/05
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer
期刊论文
INVESTIGATIONAL NEW DRUGS, 2018, 卷号: 36, 期号: 2
作者:
Ouyang, Xuenong
;
Shi, Meiqi
;
Jie, Fangwei
;
Bai, Yuxian
;
Shen, Peng
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/12/05
Phase III
Dulanermin
NSCLC
Progression-free survival
Objective response rate
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer The FRESCO Randomized Clinical Trial
期刊论文
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 卷号: 319, 期号: 24
作者:
Li, Jin
;
Qin, Shukui
;
Xu, Rui-Hua
;
Shen, Lin
;
Xu, Jianming
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2019/12/05
Results of a Randomized, Double- Blind, Placebo- Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 4
作者:
Xu, Jianming
;
Kim, Tae Won
;
Shen, Lin
;
Sriuranpong, Virote
;
Pan, Hongming
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study
期刊论文
FUTURE ONCOLOGY, 2018, 卷号: 14, 期号: 20
作者:
Li, Jin
;
Xu, Ruihua
;
Qin, Shukui
;
Liu, Tianshu
;
Pan, Hongming
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
aflibercept
Asia-Pacific
FOLFIRI
mCRC
oxaliplatin-pretreated
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
期刊论文
GASTRIC CANCER, 2016, 卷号: 19, 期号: 1
作者:
Wang, Jinwan
;
Xu, Ruihua
;
Li, Jian
;
Bai, Yuxian
;
Liu, Tianshu
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
Advanced gastric cancer
Modified docetaxel and cisplatin plus fluorouracil regimen
Progression-free survival
Overall survival
Safety
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
期刊论文
LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 6
作者:
Li, Jin
;
Qin, Shukui
;
Xu, Ruihua
;
Yau, Thomas C. C.
;
Ma, Brigette
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/13
Effects of regorafenib therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial.
会议论文
作者:
Qin, Shukui
;
Kim, Tae Won
;
Yau, Thomas Cheung
;
Ma, Brigette
;
Pan, Hongming
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/19
A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer
会议论文
作者:
Xu, Rui-Hua
;
Shen, Lin
;
Wang, Keming
;
Wu, Gang
;
Shi, Chunmei
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/19
©版权所有 ©2017 CSpace - Powered by
CSpace